跳至主要内容
临床试验/NCT01241006
NCT01241006已完成4 期

A Randomized Double-Blind Controlled Trial of Single Oral Dose Dexamethasone Versus Five Days of Oral Prednisone in Acute Mild to Moderate Adult Asthma

Alameda County Medical Center1 个研究点 分布在 1 个国家目标入组 376 人开始时间: 2011年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
376
试验地点
1
主要终点
Relapse for worsening asthma within 14 days of ED visit

研究概览

简要总结

This study seeks to compare the effectiveness of a single dose of oral dexamethasone versus 5 days of oral prednisone in the treatment of mild to moderate asthma exacerbations to prevent relapse with an unscheduled return visit to a health care provider for additional asthma treatment within 14 days. The investigators hypothesize that the two treatments will be equally effective in relapse prevention.

详细描述

Dexamethasone and Prednisone are both systemic corticosteroids. The study will compare a single dose of oral dexamethasone to 5 days of oral prednisone in the treatment of asthma. Oral corticosteroids are commonly prescribed following an asthma exacerbation as it has been demonstrated that these medications prevent relapse.

Oral prednisone is the most common corticosteroid prescribed for asthma relapse prevention. The half life is around 4 hours and is typically prescribed for minimally 5 days.

The study is evaluating the efficacy of a single dose of dexmethasone. The drug's efficicacy has been shown to be longer acting and up to 72 hours. A single dose would eliminate the need for a prescription for a drug like prednisone to hopefully improve compliance.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18-55yo
  • History of asthma
  • Requires > 1 albuterol nebulizer
  • Valid phone number

排除标准

  • declines participation
  • Past allergic reaction to corticosteroids
  • Use of Oral steroids in the last 2 weeks
  • History of COPD, pulmonary fibrosis, cystic fibrosis, or other chronic lung disease
  • History of HIV
  • History of CHF
  • History of Diabetes mellitus
  • Active chickenpox (varicella) or shingles (herpes zoster)
  • Active TB
  • Requires admission to the Hospital
  • Requires immediate airway intervention

研究组 & 干预措施

Dexamethasone

Active Comparator

Single dose of Dexamethasone 12 mg PO and 4 days of placebo capsules

干预措施: Dexamethasone (Drug)

Prednisone

Active Comparator

Prednisone 60mg PO capsules for 5 days

干预措施: Prednisone (Drug)

结局指标

主要结局

Relapse for worsening asthma within 14 days of ED visit

时间窗: 14-17 days

Relapse will be defined as un unscheduled visit to see a doctor for worsening asthma within 14 days following their ED visit for asthma

次要结局

  • Compliance(14 days)
  • Side effects(14 days)
  • Symptoms persistence or improvement(14-21 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Matthew Rehrer

Chairman of ACMC Emergency Department

Alameda County Medical Center

研究点 (1)

Loading locations...

相似试验